Dexcom rtCGMSystems demonstrate clinical and quality-of-life outcomes across various ages. RCTs have shown that rtCGM led to greater improvements in A1C and TIR than IS-CGM1 and Dexcom CGM leads to improved clinical outcomes; including lowering A1C; reducing hyper-and hypoglycaemia; and increasing TIR2. This course will guide you through the wealth of high-level; randomised control trial evidence across all ages; from young children; through the older paediatrics; teenagers; younger adults; adults; and into senior years.
At Dexcom, we believe that with diabetes, knowledge is power, we’ve spent the last 20 years innovating and developing simpler and better ways for people with type 1 diabetes to measure, track and manage their diabetes. When Dexcom was established the only way to measure glucose levels was to fingerstick, it gave us a snapshot not a story which made it difficult to understand our glucose levels and trends over time or feel in control of our diabetes. Since then, we’ve launched the world’s first real-time CGM system and helped to eliminate more than 11 billion fingersticks.
